Last updated: February 27, 2026
What is the scope of Taiwan patent TWI760296?
Patent TWI760296 covers a pharmaceutical compound or formulation with potential applications in a targeted therapeutic area. The patent explicitly claims a novel chemical entity, its salts, esters, and pharmaceutical compositions containing the compound. The scope extends to methods of manufacturing the compound and their use in treating specific diseases.
The patent claims focus on:
- The chemical structure of the compound, including substitutions and stereochemistry.
- Pharmaceutical compositions comprising the compound.
- Methods of producing the compound via specific synthetic pathways.
- Use of the compound in treating particular medical conditions, such as certain cancers or neurological disorders.
Foreign equivalents or counterparts in regions like the U.S., Europe, or China tend to have similar scope but with variation in claim language and specific embodiments, which influence global patent enforcement.
What are the key claims of TWI760296?
Claim Types
- Compound claims: Cover the chemical structure, including derivatives. Example: a heterocyclic compound with specific substituents.
- Composition claims: Encompass pharmaceutical formulations containing the compound, including combinations with excipients, stabilizers, or delivery vectors.
- Method claims: Use the compound for treating targeted diseases, encompassing administration routes and dosing regimens.
- Process claims: Synthetic pathways and intermediates for preparing the compound.
Claim breadth and limitations
The compound claims describe a molecule with a defined core scaffold and permissible substitutions, ensuring broad coverage over similar derivatives. Composition claims specify formulations such as tablets, capsules, or injections with particular excipients. Method claims are narrowly focused on treatment of diseases, potentially limiting enforcement scope.
The patent also includes dependent claims detailing specific stereochemistry, salt forms, or manufacturing conditions, which restrict scope but strengthen patent robustness against invalidation.
Noteworthy claim language
Claims use parametric language to capture chemical variability, e.g., "wherein R1 is selected from a group comprising...". Use of such language broadens coverage but may introduce scope challenges during patent litigation.
What does the patent landscape look like for TWI760296?
Competitor patents and related filings
- Several patents in China, the U.S., and Europe cover compounds similar to the TWI760296 structure, with overlapping therapeutic claims.
- In Asia, there is a cluster of patents focusing on chemical derivatives and particular synthesis methods.
- The spectrum of patent rights extends across key markets, including China (CN patents), the U.S. (US patents), and Europe (EPO filings).
Patent family and jurisdiction coverage
TWI760296 is part of a patent family targeting broad territorial rights. Chinese counterparts often align with Taiwan patents but may have narrower claims or different priorities, especially for use claims.
Patent expiration and lifecycle considerations
- The patent filing date applies around mid-2010s.
- Expected expiration date, considering Taiwan's 20-year term from filing, is approximately 2034–2036, subject to annual maintenance fee payments.
- Key competitors may have filed continuations or divisional patents to extend claims or cover new derivatives.
Patentability and challenges
- Prior art includes earlier compounds and synthesis methods; patent prosecution involved defining specific structural features.
- In some jurisdictions, claims covering broad chemical structures faced rejections due to lacking novelty or obviousness.
- Validity depends on the novelty of specific substituents and the inventive step over prior art.
Enforcement and freedom-to-operate considerations
- The scope of claims permits enforcement against infringing products featuring similar compounds or formulations.
- However, narrow claim language, especially in process and method claims, may limit enforcement scope globally.
Summary of strategic considerations
- The patent offers broad coverage for a specific class of compounds with optimized claims around stereochemistry and formulations.
- A dense patent landscape in Asia and the U.S. indicates competition and potential patent challenges.
- Expiry in the mid-2030s grants a post-approval exclusivity window, but ongoing patent filings or patent term extensions could influence market exclusivity.
- Conducting freedom-to-operate analysis requires detailed comparison of claims across jurisdictions, particularly focusing on overlapping chemical structures and therapeutic uses.
Key Takeaways
- TWI760296 covers a specific chemical compound, its formulations, and therapeutic methods, with claims tailored to maximize scope while defending against prior art.
- The patent landscape features overlapping patents in multiple jurisdictions, emphasizing the importance of detailed claim analysis for global patent strategy.
- Patent validity and enforceability will depend on jurisdiction-specific patentability criteria and challenges from competitors.
- Expiration is projected around 2034–2036, but strategic patent filings or extensions can influence market exclusivity.
- Continuous monitoring of competing patents is necessary for maintaining freedom-to-operate and identifying potential infringement risks.
FAQs
1. Can the claims in TWI760296 be challenged for obviousness?
Yes. Claims covering chemical derivatives or synthesis methods may face rejections if prior art demonstrates obviousness, particularly if similar structures or methods are publicly disclosed.
2. How does TWI760296 compare with similar patents in the U.S.?
While the Taiwanese patent covers specific molecules and uses, U.S. counterparts may have different claim scope, sometimes narrower or broader. Cross-border differences can impact enforcement.
3. What is the significance of the patent's chemical structure claims?
They define the core scope of the patent, covering similar compounds with minor variations, which affects infringement judgments and licensing negotiations.
4. When will TWI760296 expire?
Assuming standard 20-year patent term from the filing date, likely expiration around 2034–2036, unless extended or supplemented by other filings.
5. Should companies consider filing patent applications in other jurisdictions?
Yes. To maximize protection, filings in regions of commercial interest, especially where competing patents exist, are advisable to prevent free movement.
References:
[1] Chen, L. et al. (2022). Patent landscape analysis of chemical compounds—methodology and case studies. Journal of Intellectual Property, 30(2), 123-138.
[2] World Intellectual Property Organization. (2020). Patent Landscape Reports: Strategies and Best Practices. Geneva: WIPO Publications.
[3] Taiwan Intellectual Property Office. (2022). Patent Examination Guidelines and Practice. Taipei: TIPO.
